Improving Type 2 Diabetes Care with Extended-Release Metformin: Real-Life Insights from a Physician Educational Program.
Molteni L, Marelli G, Castagna G, Brambilla L, Acerbis M, Alberghina F, Carpani A, Chiavenna E, Ferlini MG, Impellizzeri C, Paredi R, Rigamonti A, Rivolta G, Disoteo OE.
Molteni L, et al. Among authors: marelli g.
Endocr Metab Immune Disord Drug Targets. 2024 Feb 28. doi: 10.2174/0118715303294909240221102552. Online ahead of print.
Endocr Metab Immune Disord Drug Targets. 2024.
PMID: 38425116